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Alzheimer’s disease is a severe irreversible syndrome, characterized by a slow and
progressive cognitive decline that interferes with the standard instrumental and essential
functions of daily life. Promptly identifying the impairment of particular cognitive functions
could be a fundamental condition to limit, through preventive or therapeutic interventions,
the functional damages found in this degenerative dementia. This study aims to
analyse, through a systematic review of the studies, the sensitivity of four experimental
paradigms (Wisconsin Card Sorting Test, Stroop Task, Go/No-Go Task, and Flanker
Task) considered as golden standard instruments for executive functions assessment in
elderly subjects affected by Alzheimer dementia. This review was carried out according
to the PRISMA method. Forty-five studies comparing the executive performance of
patients with Alzheimer’s dementia (diagnosed according to different classification criteria
for dementia) and healthy elderly patients both over the age of sixty, were selected.
For the research, PubMed, PsycINFO, PsycArticles databases were used. The study
highlighted the importance of using standard protocols to evaluate executive dysfunction
in Alzheimer’s disease. The Stroop task allows discriminating better between healthy and
pathological aging.
Keywords: alzheimer’s disease, executive functions, wisconsin card sorting test, stroop task, go/no-go task,
flanker task
INTRODUCTION
TheWorldHealth Organization defines dementia as a “loss of intellectual capability of such severity
as to interfere with the social or occupational functioning” (World Health Organization, 2010). It is
a complex irreversible and chronic syndrome (Knapp et al., 2007) in which a slow and progressive
cognitive decline affects the typical performance of the practical and essential functions of daily life
(Boccardi, 2007).
The typical symptoms of dementia involve different cognitive domains, such as memory, spatial
and temporal orienting, language and learning, comprehension, and communication skills (World
Health Organization, 1992); moreover, alterations in emotional control, motivation and social
behavior are often present (Kipps et al., 2009). This problem appears to be increasing in the general
population (World Health Organization, 2012). It is estimated that about 46.8 million people
worldwide, in 2015 had dementia; continually growing numbers that are expected to double every
20 years, reaching estimates of 74.7 million people in 2030 (Prince et al., 2016).
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The calculation of the annual health costs related to dementias
are similar to those of heart diseases, and they are much higher
than those referred to cancer. These data would place dementia
among themost expensive diseases in society (Prince et al., 2016).
Most of these costs are attributable to home care and long-term
institutionalization.
The most widespread form of dementia is Alzheimer’s
Dementia (AD), which is one of the main risk factors for death
in the affected individuals (Alzheimer’s Association, 2016).The
average duration of the disease varies between 4 and 8 years,
although some patients may survive up to 20 years after the onset
of the AD (Xie et al., 2008). Alzheimer dementia is estimated to
have increased by 35.4% in 2015, significantly raising the specific
costs of this disease (Prince et al., 2016).
Alzheimer’s disease includes a pre-dementia and a dementia
phase (Taylor and Thomas, 2013). Pre-dementia represents the
initial period of the disorder, in which the first symptoms
associated with episodic memory loss begin (starting with
the removal of the most recent memories and experiences),
symptoms that however do not interfere with the management
of the activities of the daily life (Förstl and Kurz, 1999). However,
in this Mild Cognitive Impairment condition (MCI), not amnesic
dysfunctions are also reported (Hodges et al., 2006). With the
progression of the disease and the transition to the actual
dementia phase, in addition to a worsening of the memory
symptoms (which begin to affect even themost ancient memories
and experiences), linguistic and spatial orienting deficits emerge
that involves a severe functional difficulty (Hodges et al., 2006).
High levels of anxiety and a general lack of motivation complete
the clinical profile of AD (Steinberg et al., 2008; Dening and
Sandilyan, 2015). On the other hand, in this first phase the
procedural memory is still relatively preserved, but with the
aggravation of the disease, there is a complete compromise of the
entire memory domain (Pucci, 2004).
Balota and Faust (2002) have reported that individuals with
AD present specific difficulties in selecting relevant information
by separating them from irrelevant ones, highlighting their
difficulty in dividing attention among multiple stimuli and in
the attentional control. Likewise, lexical and semantic abilities
would seem to be compromised, while phonological and syntax
abilities would seem to be relatively conserved. As the disease
progresses, the vocabulary tends to become impoverished and
phonemic, and semantic paraphasias begin to appear, with a
diminishment of expressive and understanding abilities (Pucci,
2004). In addition to language, the skills of spatial and temporal
orienting, cognitive control of behavior, visuomotor integration,
and executive functions are strongly compromised (Pucci, 2004).
Alzheimer’s disease is characterized by a complex
neuropsychological profile, associated with the gradual
degeneration of the various cortical areas affected by this
pathology. In the AD, the entorhinal cortex and the hippocampus
seem to be compromised initially, that is, the structures involved
in recording and consolidating information and in episodic
memory (Du et al., 2001). Moreover, some studies have shown
that patients with Alzheimer’s disease showed severe lesions
in the hippocampal and parahippocampal regions and the medial
temporal lobe (Prvulovic et al., 2002; Machulda et al., 2003).
The AD, except the rare forms caused by genetic anomalies,
derives from the presence and interaction of different conditions
(Ngandu et al., 2015). Late age (Hebert et al., 2013), familiarity
(Green et al., 2002) and the inheritance of the APOE-4 gene
(Farrer et al., 1997) represent the risk factors most associated
with the AD. Smoking, obesity (Beydoun et al., 2014), diabetes
(Reitz et al., 2011), low levels of education and the inability to
remain socially and mentally active, making it impossible to rely
on their reserves cognitive (Wang et al., 2012) that, when are low,
would be included among the risk factors indirectly associated
with Alzheimer’s disease. Regular physical activity (Sofi et al.,
2011), a diet low in saturated fats (Loef and Walach, 2012), good
cardiovascular health and the absence of brain lesions (McKee
et al., 2013) represent protective factors for cognitive decline.
EXECUTIVE FUNCTIONS IN ALZHEIMER’S
DISEASE
Executive functions represent a wide range of active cognitive
processes, which allow responding in the appropriate way to
environmental stimuli. This “umbrella term” includes verbal
reasoning, problem-solving, planning, the ability to maintain
sustained attention, resistance to interference, multitasking,
cognitive flexibility, and the ability to cope with novelty (Stuss
and Benson, 1986; Shallice, 1988; Damasio, 1995; Stuss et al.,
1995; Grafman and Litvan, 1999; Burgess et al., 2000). To
facilitate research in the field of Executive Functions, several
authors (Miyake et al., 2000; Lehto et al., 2003; Diamond, 2013)
have developed a tripartite classification that consists of:
- Inhibition, including inhibitory control, self-control
(behavioral inhibition), and interference control (selective
attention and cognitive inhibition). It includes the voluntary
inhibition of dominant or automatic responses (Miyake
et al., 2000) and would allow controlling behavior, thoughts
and emotions, as well as attentional aspects, with the aim to
respond appropriately to the needs of the task and specific
objectives (Diamond, 2013);
- Updating, which allows keeping in mind and manipulating
information. It involves the updating and the monitoring
of the representations collected in the working memory
(involvement of the Dorsolateral Prefrontal Cortex; Miyake
et al., 2000), which allow responding appropriately to
external tasks or stimuli, thanks to the processing of relevant
information (Miyake et al., 2000);
- Cognitive flexibility (set-shifting), which allows modifying
one’s behavioral response to external stimuli (Baddeley and
Hitch, 1994; Smith and Jonides, 1999; Diamond, 2013). It is
characterized by the attentional shift between tasks or between
different mental operations. This mechanism is commonly
regarded as disengagement from an irrelevant task with
subsequent anchorage on a relevant task to pursue a particular
objective (Miyake et al., 2000). Diamond (2013) referring
to this specific executive function uses the term Cognitive
Flexibility, which allows underlining the ability to change the
individual perspective not only from a spatial point of view but
also by interpersonal and thoughtful perspectives.
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Until the last 20 years, deficits in executive functions were rarely
considered in the early stages of Alzheimer’s disease (Allain et al.,
2013). Some studies suggested that these were relatively preserved
during the pre-clinical phase of the disorder (Broks et al., 1996;
Razani et al., 2001). However, over the last years, this view has
changed, and more recent studies have confirmed the presence
in the AD of early impairment in a variety of tasks aimed at
investigating executive functions (Binetti et al., 1996; Amieva
et al., 2002; Bondi et al., 2002). These findings confirm that in
the Alzheimer’s disease executive functions are impaired from
the early stages (Levy et al., 2002), primarily due to degeneration
of the prefrontal cortex (Salat et al., 2001). In particular, the
inhibitory abilities (Amieva et al., 2004), the attentional (Perry
and Hodges, 1999) and the visuospatial functions (Cronin-
Golomb and Amick, 2001) would be specifically compromised.
In patients with the AD, the attentional skills needed to resolve
complex tasks would be impaired, such as divided attention, the
ability to effectively disengage and shift attention (Perry and
Hodges, 1999) and sustained attention (Berardi et al., 2005).
Moreover, about the visuospatial functions the constructive
praxia, visual-perceptive, and visual orienting abilities would
seem to be damaged (Cronin-Golomb et al., 2007). When
these cognitive deficits interfere with the performance of
daily life activities, the patient can react to his/her cognitive
impairment with mood swings, irritability and apathy. All these
aspects outline the characteristic clinical profile associated with
Alzheimer’s disease.
Considering the relevance that the AD has on the life of
patients affected by this disease, it is essential to understand
the specific alterations involving the executive functioning
thoroughly. With this purpose, recently, many researchers have
focused on the use of experimental paradigms aimed at analyzing
the deficits of executive functions in individuals affected by
dementia (Sgaramella et al., 2001; Bullock and Lane, 2007;
Cronin-Golomb et al., 2007; Ramanan et al., 2017). These studies
highlighted how the various executive functions (Miyake et al.,
2000) are differently affected by AD depending on the stage of
the disease and by the personal characteristics of the patients.
COGNITIVE TASKS AND ASSESSMENT OF
COGNITIVE FUNCTIONS IN ALZHEIMER’S
DISEASE
Different experimental paradigms were used to evaluate
executive functions in the AD. (Perry and Hodges, 1999) Given
the heterogeneity of these paradigms and the vastness of studies
aimed at investigating executive performance in patients with
the AD, the objective of this review is to analyse the researches
that address this issue through four specific behavioral tasks:
Stroop Task, Wisconsin Card Sorting Test, Flanker Task, and
Go/No-Go Task. These tasks were more commonly used to
evaluate executive performance (Diamond, 2013).
Stroop Task (Stroop, 1935) is one of the most used paradigms
for the study of executive functions. In particular, through the
use of incongruent stimuli, it evaluates the management of the
conflict and the inhibitory control of automatic responses. In
the standard version of the Stroop Task, the stimuli are words
written with colored inks. There are congruent (the word RED
written in red ink) or incongruent (the word RED written in
green ink) trials; the participant’s goal is to respond by referring
to the color of the ink ignoring the meaning of the word. In this
way, two alternative and incompatible responses (color vs. word)
are elicited, one of which is more spontaneous than the other
(reading of the word vs. ink color denomination).
The Wisconsin Card Sorting Test (WCST) (Milner, 1963) is
aimed to evaluate abstract reasoning, and cognitive flexibility
understood as the ability to change one’s strategies in response
to environmental contingencies (Berg, 1948; Grant and Berg,
1948; Luria, 1973; Shallice, 1982). The WCST consists of four
stimulus cards and two sets of 64 response cards. The cards
vary in color, shape and number of elements represented. The
test includes some ambiguous stimuli, and the pairing criteria
vary according to a standardized order (Color, Form, Number).
The task requires identifying the correct criterion with which
to order the response cards to the stimulus cards; for each card
placed by the participant, the experimenter provides feedback on
the correctness of the performance. Based on the feedback from
the experimenter, the participant can modify his/her behavior by
identifying the appropriate strategy.
The Flanker Task (Eriksen and Eriksen, 1974) measures
selective attention and the ability to control conflictual
information. The task requires discriminating the central target
stimulus between a series of lateral distractors (flanker). There
are three types of conditions: the congruent trials, in which the
target stimulus and the flankers have the same characteristics
and required the same response; the incongruent trials, in which
the target has different features with respect to the distractors,
requiring an opposite response that generates conflict; finally, the
neutral condition, in which the distractor is not confused with the
targets presented in the task, and it does not cause conflict. The
flanker effect (also called conflict or congruence effect) reveals the
difficulty in ignoring the distractors due to the ambiguity of the
stimuli used (Cohen and Shoup, 1997).
The Go/No-Go Task assesses sustained attention (vigilance)
and impulsivity and allows obtaining information related
to motor-type inhibitory control (Zahn et al., 1980, 1991;
McGaughy and Sarter, 1995). The task consists in the
presentation of a stimulus that requires a response from the
participant (Go stimulus), and another stimulus for which the
participantmust, instead, inhibit any response (No-Go stimulus).
A high percentage of errors indicates a difficulty in behavioral
inhibition. Also, in this case, there are different versions of the
task to investigate the inhibitory aspects and the influences of this
ability from other variables, such as emotions (Schulz et al., 2007).
AIMS
The central aim of this review is to analyse the sensitivity of four
experimental paradigms (Stroop Task, Flanker Task, Wisconsin
Card Sorting Test and Go/No-Go Task) in the study of executive
functions in elderly subjects suffering fromAlzheimer’s dementia,
in order to be able to consider and define the applicability and
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usefulness of these paradigms. Moreover, another objective of
this work is to verify how the executive functioning in the AD
is compromised concerning the normal operation of healthy
elderly, with the aim of understanding how and where the
cognitive impairment associated with dementia intervenes in a
more evident way.
SYSTEMATIC REVIEW
The systematic review was conducted using the PRISMAmethod
(Moher et al., 2009), but without recording the protocol. This
review considered all the works that investigated the executive
functioning through the use of the cognitive tasks defined in the
introduction.
Most of the considered studies refer to the diagnostic criteria
of Alzheimer Disease of the National Institute of Neurological
and Communications Disorders and Stroke and the Alzheimer’s
Disease and Related Disorders Association (NINCDS-ADRDA)
(McKhann et al., 1984) for the classification of the AD. However,
we considered also the studies that used the diagnosis criteria
of DSM (American Psychiatric Association, 1980, 1994), the
Cambridge Diagnostic Examination of Elderly (CAMDEX)
(Roth et al., 1986) or National Institutes of Health and the
Alzheimer’s Association published revised guidelines (NIA-AA)
(McKhann et al., 2011).
METHOD
The study was the result of systematic research in the PubMed,
PsycArticles, and PsycINFO databases. The following keywords
were used for the search: Stroop Task, Wisconsin Card Sorting
Test, Go/No-Go Task, Flanker Task, and Alzheimer. Thespecific
scripts are presented in Table 1.
All articles published on the topic up to the date of 1 July 2018
have been taken into account.
Two researchers performed the research independently, and
the results were compared. The disagreements have been resolved
with consensus methods. In case of lack of consensus among the
researchers, a supervisor was used.
For the selection of the articles the following inclusion criteria
were used: publications on “Peer Review-Journals”; use of the
Stroop Task, the Flanker Task, the Wisconsin Card Sorting Test
or, the Go/No-Go Task; the presence of a control group of healthy
elderly.
The exclusion criteria were the following: (a) studies that
did not present all the data useful for a critical analysis
of the results; (b) the use of versions of the tasks that
considered the emotional components of executive functions; (c)
studies with methodological bias (for example with unspecified
inclusion/exclusion criteria); (d) studies comparing the AD
group with groups affected by other types of dementia or MCI
without a healthy elderly group; single cases.
The initial results produced 858 articles. After the elimination
of duplicates and irrelevant papers, by the title and abstract
reading, 83 articles were read.
TABLE 1 | Scripts used in the systematic research.
Script
Alzheimer and
Stroop Task
(“Alzheimer disease”[MeSH Terms] OR (“Alzheimer”[All
Fields] AND “disease”[All Fields]) OR “Alzheimer
disease”[All Fields] OR “Alzheimer”[All Fields]) AND
(“Stroop test”[MeSH Terms] OR (“Stroop”[All Fields] AND
“test”[All Fields]) OR “Stroop test”[All Fields] OR
(“Stroop”[All Fields] AND “task”[All Fields]) OR “Stroop
task”[All Fields]).
Alzheimer and
Flanker Task
(“Alzheimer disease”[MeSH Terms] OR (“Alzheimer”[All
Fields] AND “disease”[All Fields]) OR “Alzheimer
disease”[All Fields] OR “Alzheimer”[All Fields]) AND
Flanker[All Fields] AND Task[All Fields].
Alzheimer and
Go/No-Go
(“Alzheimer disease”[MeSH Terms] OR (“Alzheimer”[All
Fields] AND “disease”[All Fields]) OR “Alzheimer
disease”[All Fields] OR “Alzheimer”[All Fields]) AND
Go/No-Go[All Fields] AND Task[All Fields].
Alzheimer and
Wisconsin Card
Sorting Test
(“Alzheimer disease”[MeSH Terms] OR (“Alzheimer”[All
Fields] AND “disease”[All Fields]) OR “Alzheimer
disease”[All Fields] OR “Alzheimer”[All Fields]) AND
(“Wisconsin card sorting test”[MeSH Terms] OR
(“Wisconsin”[All Fields] AND “card”[All Fields] AND
“sorting”[All Fields] AND “test”[All Fields]) OR “Wisconsin
card sorting test”[All Fields]).
At the end of the revision work, 45 articles were included
in the review. The flowchart presented in Figure 1 shows the
selection of the studies.
The 45 selected articles have been categorized concerning
the single paradigm used. Studies that used more experimental
tasks were discussed in the different paragraphs concerning the
results of each specific task. According to PICOS (Moher et al.,
2009), information about participants, control groups, methods
and results have been extracted. These data are presented in the
different behavioral task tables.
RESULTS
Stroop Task
The systematic research has allowed the identification of 30
studies (see Table 2) that used different versions of the Stroop
Task to evaluate inhibitory control and selective attention in
patients with Alzheimer’s disease.
Within the 30 studies, only five of these did not use the
diagnostic criteria of the National Institute of Neurological
and Communicative Disorders and the Alzheimer Disease
Association (McKhann et al., 1984), in particular, Koss et al.
(1984) used the criteria for the diagnosis of AD diagnosis
of DSM-III, medical observation and scores obtained at the
Dementia Rating Scale (DRS) (Mattis, 1988); Li and collaborators
(Li et al., 2009, 2011), have used the diagnostic criteria of the
DSM-IV; (Fisher et al., 1990)used the Blessed Dementia Scale
(Blessed et al., 1968) and Hutchison and colleagues (Hutchison
et al., 2010) used the Clinical Dementia Rating Scale (CDR)
(Morris, 1993).
The patients with the AD and their control groups included
all participants over 65 years old, who differed from each other
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FIGURE 1 | The flowchart of the studies selection.
for the scores obtained at the Mini-Mental State Examination
(MMSE) (Folstein et al., 1975) or the DRS for the evaluation of
the severity of dementia. Only in the study of Tse and colleagues
(Tse et al., 2010), there was a significant difference between
the age of patients with the AD and the healthy elderly group
(patients with AD were older than people of the control group).
Compared to the Stroop Task analysis, all authors evaluated
at least one of the following dependent variables: accuracy of
responses, reaction times and interference effect (or Stroop
effect).
In most of the studies, the analysis of accuracy showed worse
performance in the patients with AD compared to healthy elderly
(Koss et al., 1984; Spieler et al., 1996; Amieva et al., 2002, 2004;
Bondi et al., 2002; Belleville et al., 2006, 2008; Duong et al., 2006;
Stokholm et al., 2006; Collette et al., 2007; Doninger and Bylsma,
2007; Bélanger et al., 2010; Hutchison et al., 2010; McGuinness
et al., 2010; Tse et al., 2010; Li et al., 2011; Stawarczyk et al., 2012;
Chen et al., 2013; Peltsch et al., 2014; Sánchez-Benavides et al.,
2014; Huang et al., 2017).
Furthermore, in all studies that also evaluated reaction
times, it was found that patients with Alzheimer’s disease
are generally slower than healthy elderly people; (Koss et al.,
1984; Spieler et al., 1996; Bondi et al., 2002; Amieva et al., 2004;
Levinoff et al., 2004; Duong et al., 2006; Stokholm et al., 2006;
Collette et al., 2007; Li et al., 2009; Bélanger et al., 2010; Hutchison
et al., 2010; Tse et al., 2010) this result was not observed by
Stawarczyk et al. (2012) that found similar reaction times in the
two groups.
In the studies identified by systematic research, several
indices were used to detect deficits in the inhibitory control
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through the Stroop Task. The most commonly used is the
Interference Effect Index, generally calculated through the ratio
or subtraction of the performance values (on reaction times or
Accuracy) between the Neutral condition (Color or Word) and
the interference condition (Color-Word). The results showed a
higher interference effect in the patients with AD groups than in
the healthy elderly people (Fisher et al., 1990; Levinoff et al., 2004;
Duong et al., 2006; Collette et al., 2007; Li et al., 2009; Tse et al.,
2010; Yun et al., 2011; Stawarczyk et al., 2012). The interference
effect can also be considered as a measure of inhibition, and
patients with AD would exhibit lower inhibitory ability than
healthy participants (Amieva et al., 2004; Belleville et al., 2006).
In addition, some studies have evaluated additional indices and
effects: among these, Spieler and colleagues (Spieler et al., 1996)
have identified a higher facilitator effect in patients with AD
in the congruent trials of the Stroop Task; while Amieva and
collaborators (Amieva et al., 2004) have shown a higher difficulty
of patients with Alzheimer’s disease in inhibiting previously
imposed rules.
Wisconsin Card Sorting Test
The systematic research allowed highlighting 14 studies (see
Table 3) that used theWCST to investigate the executive function
in patients with Alzheimer’s disease. For this purpose, different
versions of the test were used.
Almost all the studies used the diagnostic criteria NINCDS-
ADRDA (McKhann et al., 1984) for the probable diagnosis
of the AD. Hart et al. (1988) used non-specific criteria and
the DRS score to define the AD; Bhutani et al. (1992) took
into consideration the criteria of the Cambridge Diagnostic
Examination of the Elderly (CAMDEX) (Roth et al., 1986);
Chiu et al. (2014) used the criteria of the National Institutes
of Health and the Alzheimer’s Association, published revised
guidelines (NIA-AA) (McKhann et al., 2011). Also, in this case,
the participants were tested with the MMSE or DRS to verify the
level of cognitive decline, except Chen et al. (2009) who took into
account the IQ score to classify patients with the AD.
Concerning the characteristics of the groups, most of the
studies matched healthy controls with patients with AD disease
about age (considering an average age of over 65) and education.
Redondo et al. (2016) and Peltsch et al. (2014) paired patients and
healthy people only by considering years of education, groups of
patients with AD were older than controls. In the Chiu study
(2013), the AD group had lower education than healthy adults.
Finally, the study by Kugo et al. (2007) considered patients with
AD older and with lower levels of education compared to healthy
controls.
Some of these studies compared the WCST performance of
patients with the AD with that of patients with MCI, as well as
with the healthy elderly group (Tei et al., 1997; Kugo et al., 2007;
Chen et al., 2009; Chiu et al., 2014; Peltsch et al., 2014).
To evaluate performance in WCST, all studies used at least
two of the following scores: number of completed categories,
perseverative errors, total errors, and non-perseverative errors.
The results showed that patients with Alzheimer’s disease
complete fewer categories (Bondi et al., 1993; Paulsen et al., 1995;
Paolo et al., 1996; Stokholm et al., 2006; Kugo et al., 2007; Chen
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TABLE 3 | Some characteristics of the studies that have used the Wisconsin Card Sorting Test to assess executive dysfunction in patients with Alzheimer’s disease.
Studies Participant N
(mean age ± SD)
MMSE Diagnostic
criteria for AD
WCST typologies Differences between AD
group and CG group
Hart et al.,
1988
CG = 18 (70.6 ± 5.2)
[78%F]
CDR Non-specific
criteria
mWCST (modified version: 72 cards):
no ambiguous cards; after six correct
responses there was the category
shifting; no information about the shift
in sorting (Nelson, 1976).
Achieved Categories: AD<CG
DEP = 17 (69.3 ±
6.2) [65%F]
Number of Errors: AD>CG
Mild AD = 18 (71.6 ±
6.4) [76%F]
Perseverative Errors: AD>CG
Moderate AD = 16
(72.1 ± 6.8)
Bhutani et al.,
1992
CG = 12 (63.7 ±
8.27)
CG = 28. 8 ±
1.64
CAMBEX WCST (original version: 128 cards)
(Milner, 1963).
Achieved Categories: AD = CG
MinimallyAD =11
(71.5 ± 7.97)
Minimally
AD = 25.5 ±
3.69
Perseverative Errors: AD = CG
Mildly AD = 6 (74 ±
12.88)
Mildly AD = 18.7
± 2.73
Non-Perseverative Errors:
AD = CG
Moderately AD = 8
(79.7 ± 6.45)
Moderately
AD = 11.81 ±
3.95
Bondi et al.,
1993
CG = 75 (71.1 ± 7.6)
[48F]
CG = 28.9 ±
1.2
NINCDS-ADRDA mWCST (modified version: 48 cards):
no ambiguous cards; after six correct
responses subject was informed of a
shift in sorting principles (Nelson,
1976).
Achieved Categories: AD<CG
Mild AD = 23 (72.7 ±
5.9) [12F]
Mild AD = 23.9
± 2.3
Perseverative Errors: AD>CG
Moderate AD = 33
(72.3 ± 5.9) [20F]
Moderate
AD = 21.2 ± 2.9
Non-Perseverative Errors:
AD>CG
Severe AD = 31
(71.8 ± 7.9) [14F]
Severe
AD = 17.8 ± 3.7
Paulsen et al.,
1995
CG MiddleAge = 20
(49.7 ± 13.9)
[10M;10F]
DRS Middle Age
CG = 141.3 ±
2.7
NINCDS-ADRDA mWCST (modified version: 48 cards):
no ambiguous cards; after six correct
responses subject was informed of a
shift in sorting principles (Nelson,
1976).
Achieved Categories: AD<CG
Elderly CG = 20
(69.7 ± 8.2)
[10M;10F] AD = 20
(70.0 ± 6.9) [10M;10]
Elderly
CG = 140.1 ±
2.3
Correct Responses: AD<CG
HD = 20 (69.7 ± 8.2)
[12M;8F]
AD = 121.4 ±
8.6
Perseverative Errors: AD>CG
HD = 120.3 ±
9.6
Paolo et al.,
1996
CG = 35 (71.34 ±
7.73) [22M;13F]
DRS NINCDS-ADRDA WCST-64: classical WCST rules, but
in a short version (Heaton, 1981).
Achieved Categories, Trials to
complete the 1 st category,
Number of Errors, Perseverative
Responses, Perseverative Errors,
Non-Perseverative Errors,
Percent Conceptual Level
Response: AD worse than CG.
PDN = 35 (70.51 ±
5.55) [22M;13F]
Failure to Maintain Set:
AD = CG.
PDD = 35 (71.77 ±
6.31) [22M;13F]
(Continued)
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TABLE 3 | Continued
Studies Participant N
(mean age ± SD)
MMSE Diagnostic
criteria for AD
WCST Typologies Differences between AD
group and CG group
AD = 35 (71.06 ±
5.75) [22M;13F]
Tei et al.,
1997
CG= 30 (65.1±8.2) CG = 29.1±0.6 NINCDS-ADRDA
MSI = Hacinski
ischemic score >7
WCST (original version: 128 cards)
(Milner, 1963).
Achieved Categories: AD<CG
AD = 22 (67.3±9.1) AD = 23.6±1.4 Perseverative Errors: AD >CG
MCI = 22 (68.6±7.3) MCI = 24.6±2.0
Nagahama
et al., 2003
CG = 22 (70.8 ± 9.1) CG = 29.1 ±
0.8
NINCDS- ADRDA mWCST (computer version) 48 cards
no ambiguous cards; participant was
informed of the three possible
categories before testing; after six
correct responses there was the
category shifting; no information
about the shift in sorting (Nelson,
1976; Jenkins and Parsons, 1978).
Total Errors, Trials to complete
the 1stcategory, Perseverative
Errors: AD>CG;
AD = 54 (74.2 ± 5.1) AD = 20.8 ± 3.3 DSM-III-R Achieved Categories,
Non-perseverative Errors,
Conceptual level responses:
AD<CG.
MCI= 17 (72.8 ± 5.4) MCI = 26.4 ±
2.0
Stokholm
et al., 2006
CG = 32 (74.3 ± 4.2) CG = 29.3 ±
0.9
NINCDS- ADRDA mWCST (modified version: 48 cards):
no ambiguous cards; after six correct
responses subject was informed of a
shift in sorting principles (Nelson,
1976).
Achieved Categories: AD>CG
AD = 36 (76 ± 5.6) AD = 25 ± 1.5 Number of Errors: AD = CG
Perseverative Errors: AD = CG
Kugo et al.,
2007
CG = 25 (63.7 ± 2.4)
[12M;13F]
CG = 28.2 ±
1.9
NINCDS- ADRDA KWCST (Keio version): participant
was informed about the presences of
three categories (Abe et al., 2004).
Achieved Categories: AD>CG
AD = 58 (75.3 ± 7.8)
[14M;44F]
AD = 19.3 ± 4.1 CDR Perseverative Errors: AD = CG
VaD = 24 (75.1 ±
9.3) [10M;14F]
VaD = 20.7 ±
4.7
FTD= 23 (64.7 ± 9.5)
[9M;14F]
FTD = 19.6 ±
5.9
Chen et al.,
2009
CG = 16 (69 ± 8.4)
[9M;7F]
CDR NINCDS-ADRDA mWCST (modified version: 48 cards):
no ambiguous cards; after six correct
responses subject was informed of a
shift in sorting principles (Nelson,
1976).
Achieved Categories: AD<CG
Early AD = 11 (76.7
± 8.5) [7M;4F]
Mayo Clinic
Criteria for aMCI
Perseverative Errors: AD>CG
aMCI = 13 (73.2 ±
9.3) [8M;5F]
Chiu et al.,
2014
CG = 30 (64.4 ± 9.5)
[13M;17F]
CG = 28.8 ±
1.6
NIA-AA WCST (original version: 128 cards)
(Milner, 1963).
Achieved Categories: AD<CG
Early AD = 10 (69.3
± 9.4) [4M;6F]
Early AD = 22.7
± 3.6
Perseverative Errors: AD = CG
MCI = 20 (71.2 ±
9.7) [9M;11F]
MCI = 26.3
±2.7
Peltsch et al.,
2014
CG = 72 (73±6)
[22M;50F]
CG = 29 ± 1 NINCDS-ADRDA WCST (original version: 128 cards)
(Milner, 1963).
% Errors: AD>CG
aMCI = 22 (76±8)
[10M;12F]
aMCI = 27 ± 2
Mild AD = 24 (76±8)
[9M;15F]
Mild AD = 27 ±
2
(Continued)
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TABLE 3 | Continued
Studies Participant N
(mean age ± SD)
MMSE Diagnostic
criteria for AD
WCST Typologies Differences between AD
group and CG group
Huang et al.,
2017
CG = 31 (76.5 ± 5.9)
[45.2%F]
CG = 27.0 ±
1.2
NINCDS- ADRDA WCST-64: classical WCST rules, but
in a short version. (Heaton, 1981;
Kongs et al., 2000).
Achieved Categories: AD = CG
Mild AD = 31 (78.9 ±
6.3) [64.5%F]
Mild AD = DSM-IV-TR Perseverative Errors: AD = CG
21.2 ± 3.2 CDR
Redondo
et al., 2016
CG = 23 (70.92 ±
4.25) [11M;12F]
CG = 28±1.61 NINCDS-ADRDA WCST (original version: 128 cards)
(Milner, 1963).
% perseverative responses:
AD>CG
DiabetesG = 20
(70.82 ± 3.55)
[12M;8F]
DiabetesG =
26.57 ±1.95
% perseverative errors: AD>CG
AD = 22 (77.74 ±
3.90) [16M;6F]
AD= 23.71±4.25
MMSE, Mini-Mental State Examination; AD, Alzheimer Disease Group; WCST, Wisconsin Card Sorting Test; CG, Control Group; DEP, Depression Group; CDR, Clinical Dementia Rating
Scale; mWCST, Modified version of the Wisconsin Card Sorting Test; CAMBEX, Cambridge Diagnostic Examination of the Elderly; NINCDS-ADRDA, National Institute of Neurological
and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association; HD, Huntington’s Disease; DRS, Dementia Rating Scale; PDN, Parkinson
Disease without Dementia; PDD, Parkinson Disease with Dementia; MCI, Mild Cognitive Impairment; VaD, Vascular Dementia; FTD, Frontotemporal Dementia; KWCST, Keio Version of
the Wisconsin Card Sorting Test; aMCI, Amnestic Mild Cognitive Impairment; NIA-AA, National Institute on Aging and Alzheimer’s Association.
et al., 2009; Chiu et al., 2014) and commit more perseverative
errors than healthy people (Hart et al., 1988; Bondi et al., 1993;
Paulsen et al., 1995; Nagahama et al., 2003; Kugo et al., 2007;
Chen et al., 2009; Redondo et al., 2016). Nevertheless, five studies
(Bhutani et al., 1992; Tei et al., 1997; Stokholm et al., 2006;
Chiu et al., 2014; Peltsch et al., 2014; Huang et al., 2017) do
not identify differences between the numbers of perseverative
errors committed by patients compared to those of the control
group. Some of these studies (Bhutani et al., 1992; Tei et al.,
1997; Peltsch et al., 2014; Huang et al., 2017) did not identify
any difference between patients with the AD and the control
group even when they considered the number of completed
categories.
Redondo et al. (2016) identified a higher percentage of both
perseverative errors and perseverative responses in AD patients
compared to healthy older; while Nagahama et al. (2003) and
Bhutani et al. (1992) showed fewer non-perseverative errors
in patients with the AD than in healthy patients. This result
could indicate a poor set-shifting capacity in patients affected
by Alzheimer’s disease that is expressed through a general
perseveration of the responses.
Go/No-Go Task
To analyse the motor inhibition in patients with Alzheimer’s
disease, four studies (see Table 4) used different versions of
the Go/No-Go Task. All the studies used the NINCDS-ADRDA
diagnostic criteria for diagnosis (McKhann et al., 1984). All
participants (mean age over 65 years in both groups) underwent
an assessment of cognitive decline through MMSE (Amieva
et al., 2002; Stawarczyk et al., 2012; Rochat et al., 2013) or
DRS, (Collette et al., 2007) which confirmed the presence of a
higher decline in patients with AD compared to healthy controls.
Further, all studies (Amieva et al., 2002; Collette et al., 2007;
Stawarczyk et al., 2012; Rochat et al., 2013) used a group of
healthy elderly people matched by age and education to the
patient group with the AD.
The accuracy analysis was evaluated in all studies by
considering the number of errors in the No-Go trials (false
alarms). Responding to the No-Go stimulus, in fact, is viewed as
an error due to impulsivity. Concerning this result, Rochat et al.
(2013) shows a higher number of false alarms in the AD group
compared to healthy older adults. The other studies (Amieva
et al., 2002; Collette et al., 2007; Stawarczyk et al., 2012) did not
reveal any difference between patients and controls in the motor
inhibition.
Reaction times analysis, in the Go trials, was used to evaluate
the global processing speed (Amieva et al., 2002; Collette et al.,
2007; Stawarczyk et al., 2012; Rochat et al., 2013). In particular,
Collette et al. (2007) and Amieva et al. (2002) confirm a slower
performance of patients with AD compared to controls, while
Stawarczyk et al. (2012) and Rochat et al. (2013) do not report
significant differences between the groups.
The study by Stawarczyk et al. (2012) also analyzed the
preservation of inhibitory control through the analysis of
reaction times. However, they do not show any difference
between controls and patients with Alzheimer’s disease.
Moreover, Rochat et al. (2013) also considered the Counting
coefficient (Standard Deviation/Mean reaction times of the Go
Trial) and observed a higher score in patients with AD compared
to healthy people, indicating a worse performance to the
task.
Overall, the studies that used the Go/No-Go task to assess the
motor inhibitory control of patients with Alzheimer’s dementia
would seem to show a specific heterogeneity in the results. Two
of the four studies analyzed (Amieva et al., 2002; Collette et al.,
2007) tend to show a general slowdown in response times, which
would not indicate a specific deficit in motor inhibition in this
task. In contrast, only the study by Rochat and colleagues (Rochat
et al., 2013) indicates the presence of an evident executive-motor
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deficit linked to inhibitory control in patients with Alzheimer’s
disease.
Flanker Task
Four studies (Collette et al., 2009; Stawarczyk et al., 2012; Wang
et al., 2013; Chen et al., 2017) used different types of flanker tasks
inspired by the classic paradigm of Eriksen and Eriksen (Eriksen
and Eriksen, 1974), to analyses cognitive inhibition and conflict
control in patients with Alzheimer’s disease (Table 2).
All the studies used for the probable diagnosis of the AD the
diagnostic criteria NINCDS-ADRDA (McKhann et al., 1984).
In all studies, both groups (healthy elderly and elderly with
Alzheimer’s disease) have an average age over 65 years. For the
assessment of the level of cognitive impairment, the scores at
MMSE and those of the DRS were taken into consideration.
Although the authors do not report in detail the scores obtained
by the different groups, they still attest to higher cognitive
impairment in patients with the AD. Two of the studies (Wang
et al., 2013; Chen et al., 2017), compared patients with the
AD with both a healthy control group and a group of subjects
classified as MCI.
All the authors recorded reaction times and accuracy of
responses in the Flanker Task. Chen et al. (2017) compared the
performance between groups only through reaction times; this
methodological choice is justified by the fact that the authors
consider reaction times as the significant markers of cognitive
functioning because it is more closely associated with neural
functioning.
The analysis of the reaction times highlighted inconsistent
results. Wang et al. (2013) and Chen et al. (2017) reported slower
reaction times in patients with Alzheimer compared to healthy
elderly, while Collette et al. (2009) and Stawarczyk et al. (2012)
did not find significant differences between the two groups.
Analyzing accuracy, only the study by Wang et al. (2013)
showed a higher percentage of errors in patients with the AD than
in the control group. However, both general reaction times and
accuracy give a measure of selective attention, and they do not
inform about executive function.
Some of the authors (Collette et al., 2009; Wang et al., 2013)
also evaluated the flanker effect index, given by the difference
between incongruent and congruent trials in reaction times or
accuracy. Specifically, Collette et al. (2009), considering accuracy,
reported a higher flanker effect in the patients with the AD than
in the control group; Wang et al. (2013) has instead recorded
a higher flanker effect in patients the AD compared to the
healthy people by considering both reaction times and accuracy.
Moreover, Collette et al. (2009) also evaluated the facilitator effect
(comparing the accuracy of the congruent trials of the same word
and same category conditions to the neutral response condition
of Word Flanker Task; see Table 5), this effect was higher in
patients with the AD than in the two control groups (young
adults and elderly healthy subjects).
DISCUSSION
This systematic review was aimed to verify the sensitivity of
four golden standard executive functions tasks in catching
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dysfunctions in these domains in the Alzheimer’s disease. Because
executive deficits interfere with the performance of daily life
activities, by worsening the quality of life of individuals with the
AD (Wecker et al., 2000; Collette et al., 2009), it is essential to
take this cognitive dimension into account. It is important to note
that the recognition of an impairment in the executive functions
in the AD is the result of a route change, in fact until a few years
ago it was believed that the executive functions were not affected
in the pre-clinical stages of dementia (Broks et al., 1996; Razani
et al., 2001). Today it is known that these cognitive functions are
already damaged prematurely (Binetti et al., 1996; Bondi et al.,
2002; Amieva et al., 2004).
A correct choice of the cognitive tasks to use for the
assessment of cognitive impairment is a crucial element to take
into account. Those considered in this review are the most used
in the study of executive functions (Alvarez and Emory, 2006;
Duchek et al., 2009; Diamond, 2013) and are widely utilized for
cognitive assessment in patients with AD compared to healthy
elderly or other pathologies (Collette et al., 2007; Stawarczyk
et al., 2012; Peltsch et al., 2014).
They specifically evaluate the capacities of the motor (Go/No-
Go Task) and cognitive inhibition (Stroop Task), the conflict
control (Flanker Task), and the cognitive flexibility (WCST), the
ability to suppress automatic responses and the ability to “resist”
to interference (Stroop Task and Flanker task respectively); all
skills affected by cognitive decline that are specially compromise
in AD.
The Stroop Task seems to be the paradigm that best
discriminates between healthy and pathological aging, and it
is the most widely used in the research on the AD (Spieler
et al., 1996; Belleville et al., 2008; Duchek et al., 2009; Bélanger
et al., 2010; McGuinness et al., 2010; Stawarczyk et al., 2012;
Peltsch et al., 2014). A neuropsychological assessment including
this test can assess the executive system. It could highlight the
individual’s ability to move the patient’s cognitive set, providing
a measure of cognitive inhibition and attentional control, and
it gives information about the ability to inhibit an overlearned
response (i.e., a dominant response, such as the reading) in favor
of an unusual stimulus (Spreen and Strauss, 1998). One aspect to
consider about this task is that some authors (Hutchison et al.,
2010) believe that memory is entailed in the resolution process
involved in this task, the decline of which may compromise the
overall performance and hinder the ability to focusing attention
on the target.
The results obtained with the other tests were inconsistent, but
it should be noted that few studies have used them. Concerning
the ability of the Wisconsin Card Sorting Test to catch deficits
in the cognitive flexibility of Alzheimer’s disease, the results are
inconsistent. The most critical aspect related to WCST is the
complexity of the task. For this reason, some authors (Hart et al.,
1988; Bondi et al., 1993; Paulsen et al., 1995; Stokholm et al.,
2006) have introduced modified and simplified forms of this test.
Contrary to the standard version, on these modified versions of
the WSCT, there are fewer cards, and in some case, the subject
was informed about a shift in sorting principles. Moreover, there
were not ambiguous cards, and the sorting criteria changed after
six correct responses. These aspects make the task easier and
allow identifying, with higher sensitivity, the cognitive flexibility
deficits in the AD (Bondi et al., 1993; Paulsen et al., 1995;
Stokholm et al., 2006; Chen et al., 2009). If we considered
the modified versions of the test, WCST seems to discriminate
between AD patients and healthy subjects (Hart et al., 1988;
Bondi et al., 1993; Paulsen et al., 1995; Nagahama et al., 2003;
Stokholm et al., 2006; Chen et al., 2009). However, even using
a simplified version of the WCST, some studies did not find clear
differences between healthy elderly and patients with the AD.
Bhutani et al. (1992) believe that the WCST is characterized by
a “floor effect” that would not allow discriminating the normal
cognitive decline and deterioration typical of dementia, an aspect
also reaffirmed by Huang et al. (2017). Moreover, if we consider
the studies that compared the performance of patients with the
AD with those of elderly people suffering from other dementia
diseases (temporal dementia, vascular dementia, Parkinson’s with
dementia), there are no differences, suggesting that this task not
allow discriminating among different forms of dementia (Paulsen
et al., 1995; Paolo et al., 1996; Kugo et al., 2007; Li et al., 2011).
The results about the Flanker Task would seem to indicate
that this paradigm is not able to highlight a difference between
healthy and pathological elderly, especially when reaction times
are considered (Collette et al., 2009; Stawarczyk et al., 2012). The
analysis of accuracy, instead, has a higher discriminating ability to
indicate the actual deterioration in selective attention in patients
with the AD (Collette et al., 2009; Wang et al., 2013; Chen et al.,
2017). However, if we consider the only two studies that analyzed
the flanker effect, both found an impaired conflict control in
patients with AD compared to healthy people. The characteristics
of the sample represent a weak point of these studies. Two of
the four studies did not perform an exact pairing for age and
education between patients with the AD and healthy controls.
Moreover, the number of participants was very reduced (AD
group: N = 26 and Control group: N = 28; AD group: N = 15
and Control group: N = 16) (Wang et al., 2013; Chen et al.,
2017). For these reasons, and considering the few studies present,
it is not possible to exclude that the Flanker Task is sensitive to
catch impairment in selective attention and conflict control in
Alzheimer’s dementia, especially in light of the results obtained
at the Stroop Task, which involves attentional aspects similar to
those assessed by the Flanker Task (Baddeley and Hitch, 1994).
Also, the results relative to the Go/No-Go task did not indicate
whether a deficit in the control of motor inhibition is present
or not in patients with AD compared to healthy elderly. Only
one study (Rochat et al., 2013) showed a higher number of
false alarms in the AD group compared to healthy older adults,
indicating an impaired motor inhibition in the AD. The other
studies (Amieva et al., 2002; Collette et al., 2007; Stawarczyk
et al., 2012) did not reveal any difference between patients
and controls in the motor inhibition, suggesting that there
not be in AD an executive deficit of this type. This difference
between the Rochat’s study and the other studies could be due
to a different version of the Go/No-Go Task, that required
to respond to a rare target (a number); this fact involves a
harder inhibitory control ability, that could explain the difference
between AD patients and elderly healthy Control Group.
However, the comparison between patients with Alzheimer’s
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dementia and patients with different types of dementia showed
no difference (Collette et al., 2007; Kugo et al., 2007), suggesting
a pattern of motor inhibition common to the different types of
dementia.
LIMITS AND CONCLUSIONS
This review highlighted several limitations in the examination of
executive functions in Alzheimer’s disease. In particular, many
studies have used a numerically insufficient sample (Koss et al.,
1984; Bhutani et al., 1992; Belleville et al., 2006; Chen et al.,
2009; Li et al., 2009, 2011; Coubard et al., 2011; Stawarczyk
et al., 2012; El Haj et al., 2013; Wang et al., 2013) others did not
consider the level of education of the participants (Spieler et al.,
1996; Amieva et al., 2002; Belleville et al., 2006) although this
is a variable to be taken into account when analyzing executive
functions (Contador et al., 2017). A further problem is related
to the assessment of cognitive decline. The different studies
have used different scales to evaluate the cognitive decline, and
in some studies, the average scores obtained by the various
groups are not reported (Paolo et al., 1996; Spieler et al., 1996;
Collette et al., 2007; Coubard et al., 2011). Furthermore, the
severity of the decline within the AD groups varies a lot as
regards the scores at the MMSE (see Tables 2–5). This condition
does not allow controlling the influence of these variables on
the performance of the tasks used. Furthermore, some studies
not matching groups by age, gender and education, and they
have not always controlled other aspects (such as the severity
of the AD or comorbidity diseases) that could influence task
performance (Spieler et al., 1996; Amieva et al., 2002; Collette
et al., 2007; Duchek et al., 2009; McGuinness et al., 2010). These
dimensions indeed reduce the sensitivity of the instruments in
the identification of differences between groups, especially in the
case of an analysis of functions that are subject to a physiological
decline with age, as also shown by some of the studies considered
here that compare elderly control groups with younger control
groups (Spieler et al., 1996; Bélanger et al., 2010; Hutchison et al.,
2010).
Another critical point of the reviewed studies concerns the
use of multiple forms of the same experimental paradigm. These
miscellanea of test does not allow for an explicit comparison
between the various researches. Therefore, it is difficult to arrive
at definite conclusions. This aspect is particularly evident in the
studies that have used theWCST. In this case, simplified versions
of the test have shown a higher ability to identify differences
associated with the AD (Paulsen et al., 1995; Nagahama et al.,
2003; Chen et al., 2009), probably because they allow participants
to overcome the floor effect.
Concerning the Go/No-Go and the Flanker task, the results
were weak in light of the few studies found. Therefore, the
systematic use of these tests would be useful, to verify their
sensitivity to capture deficits in conflict control and motor
inhibition in the AD.
However, regardless of these limitations, at the end of this
review emerges an effective executive deficit in the inhibitory
control (Chen et al., 2013; Peltsch et al., 2014; Sánchez-Benavides
et al., 2014; Huang et al., 2017), and partly also in the cognitive
flexibility (Paulsen et al., 1995; Stokholm et al., 2006; Chiu
et al., 2014) in the AD. These results allow us to suggest
a plausible identikit of executive functioning in Alzheimer’s
disease, characterized by an impairment in inhibition and
cognitive flexibility. There are differences in performance in
the various tasks, which could reflect, as previously underlying,
differences in the levels of deterioration of the various executive
functions analyzed during the AD progression.
In the light of the results of this review that showed a more
or less marked discriminatory capacity of the examined tasks
for the identification of the executive deficits in Alzheimer’s
disease, it would be advisable to insert these tasks within
neuropsychological batteries. This could allow investigating
more entirely and articulately the cognitive functioning of
patients affected by the AD.
Overall, this review highlighted the importance of a
comprehensive neuropsychological evaluation to allow a clear
delineation of the aging profile associated with Alzheimer’s
disease.
An evaluation of this type could be inserted into pathological
aging prevention programs, and it could be useful as a form of
monitoring of executive functioning in aging. Furthermore, it
could allow identifying the presence of even slight deficits, such as
a Mild Cognitive Impairment, that could predict a degenerative
disease like the AD. MCI and AD have different diagnostic
criteria and different levels of cognitive impairment, for these
reasons MCI was not considered in this work. However, it could
be useful to conduct a systematic review taking into account the
executive performance in MCI specifically.
The results of this review would be to decline it in a meta-
analysis that could allow to better understanding the profile
of executive functions in the Alzheimer’s disease. Furthermore,
it would be advisable to carry out a comparative analysis of
the different experimental paradigms used to investigate the
individual executive functions. This comparison could allow
to a better understanding of the results obtained in this
work, consenting to conclude whether the results are univocal
regardless of the task used or if there is an effect of the type of
the task that reinforces or weakens the conclusions to which this
review has arrived.
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